| Elenitoba-Johnson, Kojo S. J. |
Sloan-Kettering Inst Can Research
United States |
Genomic biomarkers of splenic lymphoma |
5R01CA255655-06 |
|
Nicholas Hodges, Ph.D. |
| Eldridge, Ronald C |
Emory University
United States |
Integrative Multi-Omics of Metabolomics and Epigenetics to Explore thePathophysiology of Cachexia and Survival in Head and Neck SquamousCell Carcinoma |
1R03CA304028-01 |
|
Marjorie Perloff, M.D. |
| El-Serag, Hashem B |
Baylor College Of Medicine
United States |
Prevention of Hepatocellular Carcinoma Related to Metabolic Syndrome |
5P01CA263025-04 |
|
Asad Umar, D.V.M., Ph.D. |
| Eisenmann, Eric Daniel |
Ohio State University
United States |
Damage-associated molecular patterns in chemotherapy toxicity |
1R37CA299879-01 |
|
Rachel Altshuler, Ph.D. |
| Eickhoff, Jens |
University Of Wisconsin-Madison
United States |
CP-CTNet Coordinating Center |
1UG1CA304955-01 |
|
Donald Johnsey |
| Eibl, Guido Erwin Michael |
University Of California Los Angeles
United States |
Chemoprevention and mechanisms of obesity-promoted pancreatic adenocarcinoma |
5P01CA236585-05 |
|
|
| Eastham, James A |
Sloan-Kettering Inst Can Research
United States |
Influence of intra-individual variability in serial screening samples on clinical decision-making for risk stratification and biopsy by a single PSA and additional markers |
5U01CA266535-04 |
PAR-18-913 (U01 Clinical Trial Not Allowed) |
Claire Zhu, Ph.D. |
| Duvall, Adam S. |
University Of Chicago
United States |
Tailoring a fun and engaging tech-assisted cognitive behavioral therapy program for adolescents and young adults with hematological malignancies: A planning grant |
1R34CA297498-01 |
|
Brennan Streck, Ph.D., RN, M.P.H. |
| Duncavage, Eric J |
Washington University
United States |
Whole Genome Sequencing for Genomic Evaluation and Risk Stratification of Patients with Myelodysplastic Syndromes |
4UH3CA272904-02 |
|
Nicholas Hodges, Ph.D. |
| Duan, Bin |
University Of Nebraska Medical Center
United States |
Flupirtine Analogue Synthesis and Screening for the Treatment of Chemotherapy-Induced Neuropathic Pain |
1R21CA298918-01 |
|
Rachel Altshuler, Ph.D. |
